China may not allow Carlyle Group to purchase China Xugong - a major Chinese manufcturing entity
Steve Osifchin
Sep. 26, 2006

The word in Sanghai and Beijing is that Chinese manufacturing plants are being bought by Western companies for liitle money. China may not allow Carlyle Group to purchase China Xugong - a major Chinese manufcturing entity.

Tne US investment firm is trying all means to get an approval. It even agrees to invest in China Xugong but Chinese leaders are skeptical. They say the history can repeat again.

There are skepticism about Western companies buying Chinese entities for cents on the dollar.

China may not allow Carlyle Group to purchase China Xugong - a major Chinese manufcturing entity
Steve Osifchin
The word in Sanghai and Beijing is that Chinese manufacturing plants are being bought by Western companies for liitle money.
READ MORE>>

Intel claims quad core Xeon processors will get leadership back forom AMD by November but AMD has its own plans to solidify its gains
Karen Stangel
The quad core processors will be made available for Intel's server and game customers by November.
READ MORE>>

How much will Amaranth investors recover as the hedge fund finally liquidates assets
Peter Oberois
The troubled hedge fund group has finally decided to liquidate asssets and return whatever is left to the investors who trusted the hedge fund.
READ MORE>>

Calpers decision to invest in China is the worst as China is ready to plunge into multidecade depression
Sam Adelton
California Public Employees Retirement System, the largest US public pension fund will invest in Chinese companies to participate in emerging markets.
READ MORE>>

Germany's E.ON is ready to pay 38 percent more to acquire Spain's biggest power company Endesa SA
Peter Oberois
Acciona SA, Spain's fourth-largest builder will have trouble blocking the planned acquisition now.
READ MORE>>

Peugeot goes for massive cost cutting - Slash 10,000 Jobs and curtail investment - will the earnings improve?
Roselyn Seranova
Europe's second-largest carmaker is hopeful that slashing 10,000 jobs and cutting down on investments will improve the bottomline.
READ MORE>>

Merck finally is released from responsibilities in the 10th case to go to trial over the drug maker's troubled Vioxx painkiller
Arthur
There are resons for the drug maker to smile for now.
READ MORE>>

How much can J&J recover from Boston Scietific?
Sal Hirsch
The alleged suit says Guidant, now a division of Boston Scientific allowed Abbott Laboratories.
READ MORE>>

MORE ARTICLES >>